Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes.
Cole DJ, Taubenberger JK, Pockaj BA, Yannelli JR, Carter C, Carrasquillo J, Leitman S, Steinberg SM, Rosenberg SA, Yang YC. Cole DJ, et al. Among authors: leitman s. Cancer Immunol Immunother. 1994 May;38(5):299-303. doi: 10.1007/BF01525507. Cancer Immunol Immunother. 1994. PMID: 8162611 Free PMC article. Clinical Trial.
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response.
Pockaj BA, Sherry RM, Wei JP, Yannelli JR, Carter CS, Leitman SF, Carasquillo JA, Steinberg SM, Rosenberg SA, Yang JC. Pockaj BA, et al. Among authors: leitman sf. Cancer. 1994 Mar 15;73(6):1731-7. doi: 10.1002/1097-0142(19940315)73:6<1731::aid-cncr2820730630>3.0.co;2-h. Cancer. 1994. PMID: 8156501 Clinical Trial.
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.
Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R. Bishop MR, et al. Among authors: leitman s. J Clin Oncol. 2004 Oct 1;22(19):3886-92. doi: 10.1200/JCO.2004.01.127. Epub 2004 Aug 16. J Clin Oncol. 2004. PMID: 15314059 Clinical Trial.
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer.
Rosenberg SA, Lotze MT, Yang JC, Topalian SL, Chang AE, Schwartzentruber DJ, Aebersold P, Leitman S, Linehan WM, Seipp CA, et al. Rosenberg SA, et al. Among authors: leitman s. J Natl Cancer Inst. 1993 Apr 21;85(8):622-32. doi: 10.1093/jnci/85.8.622. J Natl Cancer Inst. 1993. PMID: 8468720 Clinical Trial.
Technical aspects of lymphokine-activated killer cell production.
Carter CS, Leitman SF, Cullis H, Muul LM, Nason-Burchenal K, Rosenberg SA, Klein HG. Carter CS, et al. Among authors: leitman sf. J Clin Apher. 1988;4(2-3):113-7. doi: 10.1002/jca.2920040215. J Clin Apher. 1988. PMID: 3397372
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
Fowler DH, Odom J, Steinberg SM, Chow CK, Foley J, Kogan Y, Hou J, Gea-Banacloche J, Sportes C, Pavletic S, Leitman S, Read EJ, Carter C, Kolstad A, Fox R, Beatty GL, Vonderheide RH, Levine BL, June CH, Gress RE, Bishop MR. Fowler DH, et al. Among authors: leitman s. Biol Blood Marrow Transplant. 2006 Nov;12(11):1150-60. doi: 10.1016/j.bbmt.2006.06.015. Biol Blood Marrow Transplant. 2006. PMID: 17085308 Free article. Clinical Trial.
228 results